Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134911) titled 'Coronary MicrovAscular Diseases Intervention with Compound Danshen Dripping Pills (MAID)' on Oct. 22.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Qilu Hospital of Shandong University
Condition:
Coronary microvascular disease
Intervention:
Control group:standard therapy plus matching placebo(identical in appearance to CDDP, manufacturer: Tasly Pharmaceutical Group Co., Ltd. ), Twenty pills (27 mg each) orally, three times daily after meals.
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-10-25
Target Sample Size: Control group:248;Investigationa...